Richard Hertle is an Ophthalmology physician affiliated with Akron Children's Hospital. OpenAlex indexes 85 publications with 4,453 citations (h-index 24); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Continued Study of Artificial Vision: Evaluation of the BrainPort® System and Investigation of Visual Ambulation
Sponsor: Akron Children's Hospital
- Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome
Sponsor: Akron Children's Hospital
- Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
Sponsor: Jaeb Center for Health Research
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
100%Aminoglycoside Antibacterial100%Tobramycin-Dexamethasone100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2014–2018 per NIH RePORTER. The latest:
- The Convergence Insufficiency Treatment Trial - Attention and Reading Trial
Children'S Hospital Med Ctr of Akron
FY2018$114,235U10EY022600 - The Convergence Insufficiency Treatment Trial - Attention and Reading Trial
Children'S Hospital Med Ctr of Akron
FY2017$13,587U10EY022600 - The Convergence Insufficiency Treatment Trial - Attention and Reading Trial
Children'S Hospital Med Ctr of Akron
FY2016$213,535U10EY022600
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
David Waight, MD
Akron Children's Hospital
Ian Rossman, MD/PHD
Akron Children's Hospital
Jeffrey Hord, MD
Akron Children's Hospital
Phillip Nasrallah, MD
Akron Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”